Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAn additional revision entry, v3.6.5, has been added to the study's history, updating the version list. This change reflects an update to the record's metadata rather than substantive study content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe study record history shows a new revision label from v3.6.3 to v3.6.4. This represents an updated version of the record without altering study content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study record history now includes a new Revision: v3.6.3 entry, representing an updated version of the record; the previous Revision: v3.6.2 appears as an earlier version in the history.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry for v3.6.2 was added to the record history, and the older revision v3.6.0 was removed from the history list.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision v3.6.0 was added to the study record history. An older revision v3.5.5 was removed from the history.SummaryDifference0.6%

- Check82 days agoChange DetectedA new revision entry, Revision: v3.5.5, was added to the study record history, replacing the previous Revision: v3.5.4. This indicates an update to the record's documentation.SummaryDifference0.1%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.